ENZYMOLOGY OF RNA PROCESSING ENZYMES
RNA 加工酶的酶学
基本信息
- 批准号:6627210
- 负责人:
- 金额:$ 45.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-01-01 至 2004-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (applicant's description): Ribonuclease P (RNase P) is a
ribonucleoprotein complex that catalyzes the essential 5' maturation of
precursor tRNA (pre-tRNA). Both the protein and RNA subunits are essential for
iii vivo activity; however, the bacterial RNA component catalyzes pre-tRNA
cleavage iii vitro in high salt. Mechanistic and structural investigations of
this enzyme are crucial as RNase P and the ribosome are the only ribozymes that
function as true enzymes in vivo. In the previous grant period, we solved the
first structure of the protein component of ribonuclease P and demonstrated
that the protein enhances catalytic efficiency by binding the leader sequence
of the precursor-tRNA substrate. This function places the protein component
near the active site and for the first time demonstrates that the RNA and
protein components both contribute to molecular recognition properties. We
propose to continue investigating the structure-function properties of the
Bacillus subtilis RNase P protein using a combination of biochemical
(mutagenesis, crosslinking, kinetic analysis, isotope effects, modification
interference, and spectroscopy) and x-ray crystallographic structural
techniques. Specifically, we aim to: (1) explore the molecular recognition
properties of the single-strand RNA binding cleft in the RNase P protein and to
determine the position of this site relative to the P RNA; (2) delineate the P
protein/P RNA binding surface and define the role of specific contacts in
catalysis; (3) determine the position of catalytic metal sites and dissect the
catalytic mechanism; and (4) extend the resolution of the RNase P protein
structure, determine the structures of P protein-oligonucleotide complexes and
site-specific variants of P protein, and solve the structure of native RNase P
holoenzyme and holoenzyme-substrate complexes.
Our long-term goal is to further our understanding of (1) the mechanisms of
catalysis used by ribozymes as compared to protein enzymes, and (2) the
structures and energetics of RNA binding proteins and protein/RNA complexes.
RNase P is an ideal enzyme to compare catalytic strategies in protein and RNA
enzymes since it functions in a biosynthetic pathway in vivo. Furthermore, the
unique collaboration between the protein and RNA subunits may provide insight
into the evolution from RNA to protein catalysts. Finally, RNase P has
potential medical applications as both a novel antibiotic target, since it is
an essential prokaryotic enzyme, and as a novel tool to specifically cleave
mRNA species in vivo in gene therapy applications.
描述(申请人的描述):核糖核酸酶P(RNase P)是一个
核糖核蛋白复合物催化必需的5'成熟
前体tRNA(pre-tRNA)。蛋白质和RNA亚基对于
III体内活动;但是,细菌RNA成分催化了pre-tRNA
在高盐中的裂解III体外。机械和结构调查
这种酶至关重要,因为RNase P,核糖体是唯一的核酶
在体内充当真正的酶。在上一个赠款期间,我们解决了
核糖核酸酶P的蛋白质成分的第一结构,并证明
蛋白质通过结合领导者序列来提高催化效率
前体-TRNA底物的。此功能放置蛋白质成分
在活动地点附近,第一次证明了RNA和
蛋白质成分均有助于分子识别特性。我们
建议继续研究该结构功能
枯草芽孢杆菌RNase P蛋白使用生化的组合
(诱变,交联,动力学分析,同位素效应,修饰
干扰和光谱法)和X射线晶体学结构
技术。具体而言,我们的目的是:(1)探索分子识别
RNase P蛋白中单链RNA结合裂缝的特性
确定该位点相对于P RNA的位置; (2)描述P
蛋白质/P RNA结合表面并定义特定接触的作用
催化; (3)确定催化金属位点的位置并剖析
催化机制; (4)扩展RNase P蛋白的分辨率
结构,确定P蛋白 - 寡核苷酸络合物的结构和
P蛋白的位点特异性变体,并求解天然RNase P的结构
Holoenzyme和Holoenzyme-Substrate复合物。
我们的长期目标是进一步了解(1)
与蛋白质酶相比,核酶使用的催化作用,(2)
RNA结合蛋白和蛋白/RNA复合物的结构和能量。
RNase P是比较蛋白质和RNA中催化策略的理想酶
酶在体内的生物合成途径中起作用。此外,
蛋白质和RNA亚基之间的独特合作可能会提供洞察力
从RNA到蛋白质催化剂的演变。最后,RNase P具有
潜在的医疗应用是一种新型的抗生素靶标,因为它是
必需的原核酶,也是特定裂解的新工具
基因治疗应用中体内mRNA物种。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CAROL A FIERKE其他文献
CAROL A FIERKE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CAROL A FIERKE', 18)}}的其他基金
Disruption of transition metal homeostasis by Cd: Implications for aging
镉对过渡金属稳态的破坏:对衰老的影响
- 批准号:
8056614 - 财政年份:2010
- 资助金额:
$ 45.42万 - 项目类别:
Disruption of transition metal homeostasis by Cd: Implications for aging
镉对过渡金属稳态的破坏:对衰老的影响
- 批准号:
7874096 - 财政年份:2010
- 资助金额:
$ 45.42万 - 项目类别:
相似海外基金
Defining structure and function of GT-A fold enzymes in bacterial glycan assembly
定义细菌聚糖组装中 GT-A 折叠酶的结构和功能
- 批准号:
10752020 - 财政年份:2023
- 资助金额:
$ 45.42万 - 项目类别:
Serotonin N-Acetyl-Transferase Inhibitors for Circadian Rhythm Disorders
血清素 N-乙酰转移酶抑制剂治疗昼夜节律紊乱
- 批准号:
10522741 - 财政年份:2022
- 资助金额:
$ 45.42万 - 项目类别:
Validation of Trypanosoma cruzi dihydroorotate dehydrogenase as a drug target for Chagas´disease.
验证克氏锥虫二氢乳清酸脱氢酶作为恰加斯病的药物靶点。
- 批准号:
10658887 - 财政年份:2021
- 资助金额:
$ 45.42万 - 项目类别:
Engineering tissue inhibitor of metalloproteinases-2 (TIMP-2) for triple negative breast cancer therapy
用于三阴性乳腺癌治疗的工程组织金属蛋白酶-2 (TIMP-2) 抑制剂
- 批准号:
10177669 - 财政年份:2021
- 资助金额:
$ 45.42万 - 项目类别:
Validation of Trypanosoma cruzi dihydroorotate dehydrogenase as a drug target for Chagas´disease.
验证克氏锥虫二氢乳清酸脱氢酶作为恰加斯病的药物靶点。
- 批准号:
10454280 - 财政年份:2021
- 资助金额:
$ 45.42万 - 项目类别: